Catalyst Wire Dossier Catalyst Wire Dossier

Second-line chemotherapy (unspecified)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Second-line chemotherapy (unspecified), covering 2024-11-07 to 2024-11-07. Get the full timeline:

Most recent: Clinical Trial Update: HAI-Floxuridine, or Liver-Tx, Combined With 2nd Line Chemotherapy Versus 2nd Line Chemotherapy Alone for Patients With Colorectal Liver Metastases and Heavy Tumour Burden. [Phase 2]

See pricing